ACE and Cognitive impairment: Despite the lack of a clear drug class superiority from the available clinical evidence, putative specific benefits have been described for calcium channel blockers, ACE-inhibitors, and sartans in basic research studies, altogether supporting their preferential use in the old hypertensive patient against cerebrovascular events and cognitive impairment [43].